Short CommunicationPerceived need and availability of psychosocial interventions across buprenorphine (cas 136232-82-1) prescriber specialties
-
Add time:09/07/2019 Source:sciencedirect.com
IntroductionPsychosocial interventions are often recommended as part of buprenorphine (cas 136232-82-1) treatment for patients with opioid use disorder, but little is known about prescriber perspectives on their use and how this varies across buprenorphine prescriber specialties.
We also recommend Trading Suppliers and Manufacturers of buprenorphine (cas 136232-82-1). Pls Click Website Link as below: cas 136232-82-1 suppliers
Prev:Epidemiology of severe buprenorphine (cas 136232-82-1) exposures reported to the U.S. Poison Centers
Next:Development and validation of a HPLC method for the determination of buprenorphine hydrochloride (cas 136232-95-6), naloxone hydrochloride and noroxymorphone in a tablet formulation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Epidemiology of severe buprenorphine (cas 136232-82-1) exposures reported to the U.S. Poison Centers09/06/2019
- A comparison of buprenorphine (cas 136232-82-1) and psychosocial treatment outcomes in psychosocial and medical settings09/05/2019
- Review articleTransdermal buprenorphine (cas 136232-82-1) patch: Potential for role in management of opioid dependence09/04/2019
- Research Paper“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine (cas 136232-82-1) use in a time of treatment expansion09/03/2019
- Evaluation of an emergency department buprenorphine (cas 136232-82-1) induction and medication-assisted treatment referral program09/02/2019
- Full length articleUnderstanding the use of diverted buprenorphine (cas 136232-82-1)09/01/2019
- Effects of ascending buprenorphine (cas 136232-82-1) doses on measures of experimental pain: A pilot study08/31/2019
- buprenorphine (cas 136232-82-1) in the United States: Motives for abuse, misuse, and diversion08/30/2019
- Full length articleMaternal buprenorphine (cas 136232-82-1) treatment during pregnancy and maternal physiology08/29/2019
-
Health and Chemical more >
-
Related Products


